RetinAI Discovery favicon RetinAI Discovery VS Altris AI favicon Altris AI

RetinAI Discovery

RetinAI Discovery stands at the forefront of healthcare innovation, offering a comprehensive data management and analysis platform specifically designed for ophthalmology. The platform seamlessly integrates multiple data formats, from DICOM-compliant imaging to proprietary formats, while providing advanced AI-powered analysis capabilities for disease progression and treatment outcomes.

The platform features CE-marked AI models for OCT analysis, layer and fluid segmentation, and supports various ophthalmological conditions including AMD, DR, DME, CME, and GA. With its cloud-based infrastructure, the system enables secure global collaboration, real-time data monitoring, and automated biomarker analysis, serving both clinical practice and research environments.

Altris AI

Altris AI provides an advanced ophthalmic image management system enhanced by Artificial Intelligence, designed specifically for ophthalmologists and optometrists. This platform automatically analyzes Optical Coherence Tomography (OCT) scans to identify pathological conditions, significantly improving diagnostic workflows. It is compatible with all OCT devices and focuses on aiding eye care specialists in making more confident and accurate diagnostic decisions, reducing potential errors and the risk of burnout.

The system facilitates early detection of over 70 retina pathologies and biomarkers, including early glaucoma risk assessment and quantitative analysis for monitoring disease progression. Altris AI enhances patient care by enabling more detailed screenings, leading to earlier detection and more effective treatment strategies. It also serves as an educational tool for patients, helping them understand their condition and treatment plan, thereby increasing compliance and loyalty. The platform adheres to strict compliance standards, including FDA clearance, CE certification, GDPR, and HIPAA.

Pricing

RetinAI Discovery Pricing

Contact for Pricing

RetinAI Discovery offers Contact for Pricing pricing .

Altris AI Pricing

Free Trial

Altris AI offers Free Trial pricing .

Features

RetinAI Discovery

  • AI Analysis: CE-marked biomarkers and automatic layer and fluid segmentation
  • Data Integration: Support for multiple imaging formats and data types
  • Secure Collaboration: GDPR, HIPAA & PIPEDA compliant platform
  • Real-time Monitoring: Instant access to study progress and patient data
  • Automated Biomarker Analysis: 30+ CE marked and Research Use Only biomarkers
  • Natural Language Search: Advanced patient cohort identification
  • Multi-center Management: Centralized data collection and analysis
  • Disease-Specific Focus: Specialized tools for AMD, DR, DME, CME and GA

Altris AI

  • Automated Pathological OCT Scan Selection: Identifies relevant scans needing further review.
  • Detection of 70+ Pathologies and Biomarkers: Comprehensive analysis of retinal conditions.
  • Early Glaucoma Risk Assessment: Utilizes AI for early glaucoma detection analysis.
  • Quantitative Biomarkers Analysis: Tracks changes in pathologies over time.
  • AI-powered Optic Disc Analysis: Assesses optic disc health for conditions like glaucoma.
  • GCC Asymmetry Analysis: Complements glaucoma assessment.
  • Compatibility with all OCT devices: Integrates with existing hardware.
  • Patient Education Tool: Color-coded images help explain conditions to patients.

Use Cases

RetinAI Discovery Use Cases

  • Clinical trial data management
  • Patient monitoring and disease progression tracking
  • Multi-center research collaboration
  • Real-world evidence generation
  • Ophthalmology imaging analysis
  • Tele-ophthalmology services
  • Drug development research
  • Clinical decision support

Altris AI Use Cases

  • Assisting ophthalmologists with OCT scan interpretation.
  • Helping optometrists enhance diagnostic capabilities using OCT scans.
  • Improving patient triage in eye care clinics.
  • Enabling early detection of retinal diseases like diabetic retinopathy, AMD, and glaucoma.
  • Monitoring the progression of eye pathologies over time.
  • Educating patients about their eye conditions using visualized AI analysis.
  • Reducing diagnostic errors and burnout for eye care professionals.
  • Supporting clinical research with AI-driven OCT analysis.

Didn't find tool you were looking for?

Be as detailed as possible for better results